patents
Less Risk, More Reward in IP
August 03 by Pharmaceuticals & Biotechnology EditorRead this paper to explore the drivers shaping the re-evaluation of IP in the research and development sector and the technical features that make a platform like E-WorkBook a particularly suitable...
US Supreme Court: “Isolated DNA cannot be patented”
June 13 by Pharma IQ News- Comment from Intellectual Property specialists Marks & Clerk on US Supreme Court ruling on patentability of isolated DNA – The US Supreme Court has today dealt a blow to the worldwide...
Launch of New Targeted Therapeutics will Drive Market Growth during the Forecast Period 2010–2017
February 07 by Pharma IQ NewsLaunch of New Targeted Therapeutics will Drive Market Growth during the Forecast Period 2010–2017 Oncology Therapeutics Market, Global Product Pipeline by Phase (%), 2011 Source: GB...
Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline
October 03 by Pharma IQ NewsThe Global Coagulation Disorders Market is Forecast to Slow Down Due to a Series of Patent Expiries In 2010, the global coagulation disorders market was estimated to be worth $5.6 billion, represe...
Biosimilars: Prioritising the Emerging Market Opportunity
September 01 by Pharmaceuticals & Biotechnology EditorBy 2015, approximately USD73 billion of biologic sales are projected to lose patent protection, opening the door for the entry of biosimilar versions of these agents. The majority of agents losing p...
Patent Drafting and Claim Construction
July 15 by Alpesh PathakTo determine whether the patentee has right to exclude for a particular claimed invention, it is essential to know what is claimed and this process is called determining the scope of the inventi...
Global Intellectual Property Risks Still Misunderstood?
July 01 by Pharma IQThe days when only highly-trained lawyers could explain the concept of intangible assets and intellectual property (IP) rights are long gone. In 2011, consumers and businesses alike are well accusto...
Pharmaceutical Revenues under Threat - The Impact of Expected Major Changes and New Regulations
March 25 by Cristina FalcãoBased on new regulations, increased costs of R & D, the expiration of dozens of patents, the lack of future ‘cash cows’, the new transparency rules and the value-based pricing, pharmaceutical comp...
The Problem of Patent Trolls – What Can We Do?
January 19 by Helen WinsorPeter Kjaer, Head of Patents at Lego, joins Helen Winsor from Pharma IQ, to discuss intellectual property right trends in the Nordic region. With patent trolls still a key concern, Kjaer expla...
Reviewing Recent European Cases to Implement Best Practice Patent Filing Strategies for the Future
October 07 by Pharmaceuticals & Biotechnology EditorHow to Address the IP Issues Specifically Associated with Polymorphic Forms
September 28 by Pharma IQIt is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutica...
How to Build a Robust Patent Strategy
July 12 by Pharma IQDr. Morten Rosted, Head of Department, DK Patents, Corporate Patents & Trademarks at H. Lundbeck A/S, speaks to Pharma IQ about the spectrum of capabilities needed in biopatent design and how to...